Siegfried Barbera, SL

FDA Regulatory Profile

Siegfried Barbera, SL appears in FDA public data with 1 recall, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0149-2024, Class III) was initiated on November 20, 2023.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0149-2024Class IIIVotrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, SNovember 20, 2023